Precision Science, Proven Results.
At Telescope Therapeutics, our services are designed to fast-track drug discovery. From disease modeling to predictive analytics, we provide the tools to uncover insights and shape the future of treatment with confidence.
Revolutionizing Disease Modeling
We transform preclinical drug development by utilizing patient-derived inducible pluripotent stem cells (iPSCs) and the latest advances in organoids—cell-derived 3D organotypic models. This approach allows us to study biological processes and drug responses longitudinally, enabling us to drive, monitor, and impact disease progression. Our initial focus is on heart disease.
Unveiling Therapeutic Targets
We correlate changes in phenotypic parameters such as cell organization, cell growth, and cell viability with disease- and therapy-relevant cellular signaling events in iPSC-derived cardiomyocytes. By adapting these approaches to other cell types, we advance the discovery of new therapeutic targets.
Predicting Therapeutic Outcomes
We support preclinical drug discovery by creating opportunities to screen in human disease-relevant platforms before or after animal studies. We explore the effects of drugs in preserving or improving the function and survival of iPSC-derived cells, such as cardiomyocytes, using strategies that could lead to "clinical trials in a dish," even down to the level of individual patients.